Growth Metrics

Bioregenx (BRGX) Depreciation & Amortization (CF) (2023 - 2025)

Bioregenx has reported Depreciation & Amortization (CF) over the past 3 years, most recently at $37945.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 93.39% year-over-year to $37945.0; the TTM value through Dec 2025 reached $100076.0, down 95.49%, while the annual FY2025 figure was $75075.0, 96.62% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $37945.0 at Bioregenx, up from $12377.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $574466.0 in Q3 2024 and troughed at $1193.0 in Q2 2023.
  • A 3-year average of $193670.2 and a median of $24877.0 in 2025 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 48053.06% in 2024 and later tumbled 97.85% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $1194.0 in 2023, then surged by 48012.73% to $574466.0 in 2024, then plummeted by 93.39% to $37945.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for BRGX at $37945.0 in Q4 2025, $12377.0 in Q3 2025, and $37377.0 in Q2 2025.